Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction

  • Grant P. Redrow
    Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas
  • Charles C. Guo
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas
  • Maurizio A. Brausi
    Ausl Modena, Nuovo Ospendale Civile–S. Agostino Estense, Modena, Italy
  • Jonathan A. Coleman
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
  • Mario I. Fernandez
    Department of Urology, Clinica Alemana de Santiago, Santiago, Chile
  • Wassim Kassouf
    Division of Urology, McGill University Health Center, Montreal, Quebec, Canada
  • Francis X. Keeley
    Bristol Urological Institute, Southmead Hospital, Bristol, United Kingdom
  • Vitaly Margulis
    Department of Urology, U.T. Southwestern Medical Center, Dallas, Texas
  • Jay D. Raman
    Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania
  • Morgan Roupret
    Department of Urology, Groupe Hospitalier Pitié–Salpêtrière, Assistance Publique Hopitaux de Paris, Faculty of Medicine Pierre et Marie Curie, Institut Universitaire de Cancérologie GRC5, University Paris 6, Paris, France
  • Shahrokh F. Shariat
    Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria
  • Philippe E. Spiess
    Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, Florida
  • George N. Thalmann
    Department of Urology, University of Bern, Inselspital, Bern, Switzerland
  • Surena F. Matin
    Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas

収録刊行物

  • Journal of Urology

    Journal of Urology 197 (2), 287-295, 2017-02

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (2)*注記

もっと見る

問題の指摘

ページトップへ